Clinical trial
Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
NCT04307277 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
- Lead sponsor
- Institut Claudius Regaud
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- October 9, 2020
- Completion date
- October 31, 2032
- Enrollment
- 600 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
soft tissue sarcoma